At POY4, after PAND bone metastasis was confirmed in a needle biopsy specimen of bone metastasis, the pathological finding showed adenocarcinoma, and the IHC analysis showed a HER2 score of 3 + . The gene discussed is ERBB2; the disease is bone metastasis.